Cargando...

IDO1 Expression in Melanoma Metastases is Low and Associated with Improved Overall Survival

Indoleamine 2–3 dioxygenase 1 (IDO1) expression may contribute to immunologic escape by melanoma metastases. However, a recent clinical trial failed to identify any clinical benefits of IDO1 inhibition in patients with unresectable metastatic melanoma, and prior characterizations of IDO1 expression...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Surg Pathol
Main Authors: Lynch, Kevin T., Gradecki, Sarah E., Kwak, Minyoung, Meneveau, Max O., Wages, Nolan A., Gru, Alejandro A., Slingluff, Craig L.
Formato: Artigo
Idioma:Inglês
Publicado: 2021
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8102301/
https://ncbi.nlm.nih.gov/pubmed/33208630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAS.0000000000001622
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!